The aberrant activation of Hh-Gli signaling has been implicated in the promotion of tumorigenesis in several types of carcinoma, including hepatocellular carcinoma [6], gastric cancer [7, 8], lung cancer [9] and basal cell carcinomas [10]. This evidence concerns the gene GLI1 and carcinoma.